"10.1371_journal.pone.0134478","plos one","2015-08-06T00:00:00Z","Christiane Gerke; Anna Maria Colucci; Carlo Giannelli; Silvia Sanzone; Claudia Giorgina Vitali; Luigi Sollai; Omar Rossi; Laura B Martin; Jochen Auerbach; Vito Di Cioccio; Allan Saul","Sclavo Behring Vaccines Institute for Global Health S.r.l., Siena, Italy; Novartis Vaccines and Diagnostics, S.r.l., Siena, Italy","Conceived and designed the experiments: C. Gerke AMC C. Giannelli SS LS LBM JA AS. Performed the experiments: C. Gerke AMC C. Giannelli SS LS OR. Analyzed the data: C. Gerke AMC C. Giannelli SS CGV LS OR JA VDC AS. Contributed reagents/materials/analysis tools: C. Gerke AMC LS C. Giannelli SS OR. Wrote the paper: C. Gerke AMC C. Giannelli SS CGV LS OR JA AS.","The authors have read the journals policy and have the following competing interests: This work was supported by Novartis. CGe, AMC, CGi, SS, LS, LBM, JA, VDC, and AS are employees of Sclavo Behring Vaccines Institute for Global Health S.r.l., a GSK company, Siena, Italy. CGV is an employee of Novartis Vaccines and Diagnostics S.r.l., a GSK company, Siena, Italy. The submitted work is included in the patent applications Hyperblebbing Shigella strains WO/2011/036564 and Purification of bacterial vesicles WO/2011/036562 which have been transferred to GSK. This did not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","08","Christiane Gerke","CG",11,TRUE,1,1,1,1,TRUE,TRUE,TRUE,6,"4;6;7;8;9;11",TRUE
